PL409332A1 - Szczepy Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych - Google Patents

Szczepy Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych

Info

Publication number
PL409332A1
PL409332A1 PL409332A PL40933214A PL409332A1 PL 409332 A1 PL409332 A1 PL 409332A1 PL 409332 A PL409332 A PL 409332A PL 40933214 A PL40933214 A PL 40933214A PL 409332 A1 PL409332 A1 PL 409332A1
Authority
PL
Poland
Prior art keywords
enterococcus faecalis
strains
production
monoclonal phage
preparations
Prior art date
Application number
PL409332A
Other languages
English (en)
Other versions
PL237852B1 (pl
Inventor
Małgorzata Łobocka
Agnieszka Gozdek
Dariusz Izak
Agnieszka Zalewska
Jan Gawor
Kamil Dąbrowski
Robert Gromadka
Beata Weber-Dąbrowska
Andrzej Górski
Original Assignee
Instytut Biochemii I Biofizyki Polskiej Akademii Nauk
Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biochemii I Biofizyki Polskiej Akademii Nauk, Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk filed Critical Instytut Biochemii I Biofizyki Polskiej Akademii Nauk
Priority to PL409332A priority Critical patent/PL237852B1/pl
Priority to EP15778720.1A priority patent/EP3186361B1/en
Priority to PCT/IB2015/056607 priority patent/WO2016030872A1/en
Priority to EP18195200.3A priority patent/EP3456813B1/en
Priority to PL18195200T priority patent/PL3456813T3/pl
Publication of PL409332A1 publication Critical patent/PL409332A1/pl
Publication of PL237852B1 publication Critical patent/PL237852B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Ujawniono szczepy Enterococcus faecalis do otrzymywania monoklonalnych preparatów bakteriofagów litycznych o wysokim mianie, pozbawionych zanieczyszczeń niepożądanymi bakteriofagami, które to szczepy gwarantują produkcję bezpiecznych w stosowaniu preparatów bakteriofagowych nie będących źródłem rozsiewu genów związanych z wirulencją bakterii. Korzystnie szczepy te to: szczep Enterococcus faecalis 1679wph zdeponowanym w PCM jako B/00074 albo szczep Enterococcus faecalis 1854wph zdeponowany w PCM jako B/00075.
PL409332A 2014-08-31 2014-08-31 Szczep Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych PL237852B1 (pl)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PL409332A PL237852B1 (pl) 2014-08-31 2014-08-31 Szczep Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych
EP15778720.1A EP3186361B1 (en) 2014-08-31 2015-08-31 Enterococcus faecalis strains for the production of bacteriophage preparations
PCT/IB2015/056607 WO2016030872A1 (en) 2014-08-31 2015-08-31 Enterococcus faecalis strains for the production of bacteriophage preparations
EP18195200.3A EP3456813B1 (en) 2014-08-31 2015-08-31 Enterococcus faecalis strains for production of monoclonal phage preparations
PL18195200T PL3456813T3 (pl) 2014-08-31 2015-08-31 Szczep Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL409332A PL237852B1 (pl) 2014-08-31 2014-08-31 Szczep Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych

Publications (2)

Publication Number Publication Date
PL409332A1 true PL409332A1 (pl) 2016-03-14
PL237852B1 PL237852B1 (pl) 2021-06-14

Family

ID=54292835

Family Applications (2)

Application Number Title Priority Date Filing Date
PL409332A PL237852B1 (pl) 2014-08-31 2014-08-31 Szczep Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych
PL18195200T PL3456813T3 (pl) 2014-08-31 2015-08-31 Szczep Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL18195200T PL3456813T3 (pl) 2014-08-31 2015-08-31 Szczep Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych

Country Status (3)

Country Link
EP (2) EP3456813B1 (pl)
PL (2) PL237852B1 (pl)
WO (1) WO2016030872A1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113215111A (zh) * 2021-05-20 2021-08-06 吉林省动物疫病预防控制中心 一种噬菌体及在防治肉鸡心内膜炎中的医用用途

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102203670B1 (ko) * 2018-12-21 2021-01-15 주식회사 옵티팜 신규한 엔테로코커스균 특이 박테리오파지 eh11 및 이를 포함하는 항균 조성물
CN110129279B (zh) * 2019-04-24 2022-02-18 昆明理工大学 一种粪肠球菌噬菌体及其分离、纯化、富集和应用
CN116199750A (zh) * 2023-01-06 2023-06-02 吉林大学 一种核糖体蛋白s11及制备方法和在疫苗佐剂中的应用

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113215111A (zh) * 2021-05-20 2021-08-06 吉林省动物疫病预防控制中心 一种噬菌体及在防治肉鸡心内膜炎中的医用用途
CN113215111B (zh) * 2021-05-20 2023-02-21 吉林省动物疫病预防控制中心 一种噬菌体及在防治肉鸡心内膜炎中的医用用途

Also Published As

Publication number Publication date
EP3456813A1 (en) 2019-03-20
PL3456813T3 (pl) 2021-10-25
EP3186361A1 (en) 2017-07-05
EP3456813B1 (en) 2021-04-28
EP3186361B1 (en) 2019-06-05
WO2016030872A1 (en) 2016-03-03
PL237852B1 (pl) 2021-06-14

Similar Documents

Publication Publication Date Title
HUE059249T2 (hu) Baktériumtörzseket tartalmazó készítmények
PH12017500915A1 (en) Cd47 antibodies, methods, and uses
DK3377082T3 (da) Sammensætninger, der omfatter bakteriestammer
IL256569A (en) (r) and (s)-1-(3-(3-n,n-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-n,n'-bis(ethylene)phosphoramidate, preparations and methods for their use and preparation
LT3307288T (lt) Kompozicijos, apimančios bakterijų kamienus
HUE046221T2 (hu) Bakteriális törzseket tartalmazó készítmények
PH12017500858A1 (en) Mocrocyclic peptides useful as immunomodulators
MX2021006581A (es) Bacterias modificadas para tratar enfermedades asociadas con hiperamonemia.
PH12017500296B1 (en) Anti-tigit antibodies
DK3218509T3 (da) Mutante mikroorganismer, der er resistente over for lactose-drab
MX2017008184A (es) Nucleosidos sustituidos, nucleotidos y analogos de estos.
MY188541A (en) Besifloxacin for the treatment of resistant acne
PH12016502555A1 (en) Methods of preparing substituted nucleotide analogs
EA201790265A1 (ru) Способы получения тромбоцит-содержащих продуктов
TW201613968A (en) Compound targeting IL-23A and TNF-alpha and uses thereof
EA201692526A1 (ru) Замещенные [1,2,4]триазольные соединения
WO2018081502A8 (en) Synthetic bacteriophages and bacteriophage compositions
PH12018500379A1 (en) Biopharmaceutical compositions
MY191539A (en) Streptococcal vaccine
TN2016000435A1 (en) Novel macrocyclic compounds.
DK3630136T3 (da) Sammensætninger, der omfatter bakteriestammer
EP4241851A3 (en) Immunogenic compositions
TN2015000477A1 (en) A new bacterial lysobacter capsici strain and uses thereof
MX2019011026A (es) Nueva vacuna de adn dirigida a pd-l1 para inmunoterapia de cancer.
PL409332A1 (pl) Szczepy Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych